Explore
Validate
Learn
Functional assayAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1108189 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Lymphocyte Antigen 96 (LY96) antibody
- Antibody type
- Monoclonal
- Antigen
- Other
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 18H10
- Vial size
- 0.1 mg
Submitted references Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria.
TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock.
Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria.
Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock.
Tissières P, Dunn-Siegrist I, Schäppi M, Elson G, Comte R, Nobre V, Pugin J
Blood 2008 Feb 15;111(4):2122-31
Blood 2008 Feb 15;111(4):2122-31
TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock.
Daubeuf B, Mathison J, Spiller S, Hugues S, Herren S, Ferlin W, Kosco-Vilbois M, Wagner H, Kirschning CJ, Ulevitch R, Elson G
Journal of immunology (Baltimore, Md. : 1950) 2007 Nov 1;179(9):6107-14
Journal of immunology (Baltimore, Md. : 1950) 2007 Nov 1;179(9):6107-14
Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria.
Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J
Blood 2007 Feb 15;109(4):1574-83
Blood 2007 Feb 15;109(4):1574-83
Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock.
Pugin J, Stern-Voeffray S, Daubeuf B, Matthay MA, Elson G, Dunn-Siegrist I
Blood 2004 Dec 15;104(13):4071-9
Blood 2004 Dec 15;104(13):4071-9
No comments: Submit comment
No validations: Submit validation data